Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation
Condition(s):IBS; IBS – Irritable Bowel SyndromeLast Updated:February 8, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):IBS; IBS – Irritable Bowel SyndromeLast Updated:February 8, 2024Recruiting
Condition(s):Hyperphosphatemia; End Stage Renal DiseaseLast Updated:March 29, 2023Completed
Condition(s):HyperphosphatemiaLast Updated:March 6, 2023Completed
Condition(s):HyperphosphatemiaLast Updated:September 14, 2020Completed
Condition(s):Constipation Predominant Irritable Bowel SyndromeLast Updated:October 15, 2019Completed
Condition(s):Irritable Bowel Syndrome With Constipation (IBS-C)Last Updated:September 8, 2023Recruiting
Condition(s):HyperphosphatemiaLast Updated:March 7, 2024Completed
Condition(s):HyperphosphatemiaLast Updated:August 2, 2023Completed
Condition(s):HyperphosphatemiaLast Updated:September 8, 2021Completed
Condition(s):HyperphosphatemiaLast Updated:October 28, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.